Suara.com – a study published today, Thursday (3/11/2021), shows that the case of cervical cancer among woman The UK slumped after they received the Human Papillomavirus (HPV) vaccine.
Comparing cervical cancer and precancer rates before and after the HPV immunization program was introduced to the UK in 2008, the researchers found a substantial reduction, especially among younger women.
“Our study provides direct evidence of the effect of HPV vaccination using the bivalent Cervarix vaccine on cervical cancer incidence,” wrote the researchers, who published their study in the medical journal. The Lancet.
The reduction in risk is thought to be most noticeable in girls ages 12 to 13, reaching 87%. While in the group of girls aged 16 to 18 years, it decreased by 34%.
Also Read:
Cervical Cancer Mortality Rate Rises, Many Women Have Not Vaccinated with HPV
This study proves that cervical cancer caused by HPV can really be prevented using a reliable and safe vaccine, and can be cured if detected early and treated immediately, reports Medical Xpress.
Although this study provides evidence, the uptake and availability of the HPV vaccine is still a problem.
“Even in rich countries, such as the UK with access to free HPV immunization, uptake has not yet reached the 90% vaccination target for 15-year-old girls, as set by the WHO,” comments gynecologist Maggie Cruickshank.
According to gynecologist Mihaela Grigore, the Covid-19 pandemic also poses its own challenges, including access to affordable vaccines, infrastructure for the cold chain, shipping, and waste disposal.
Also Read:
Kesha Ratuliu and Adhi Permana Invite Millennials to Inject HPV Vaccine
– .
